Calamos Advisors LLC Uplifts Stake in Walgreens Boots Alliance Inc (NASDAQ:WBA)

Calamos Advisors LLC Uplifts Stake in Walgreens Boots Alliance Inc (NASDAQ:WBA)

Calamos Advisors LLC increased its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 7.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 293,762 shares of the pharmacy operator’s stock after purchasing an additional 20,721 shares during the period. Calamos Advisors LLC’s holdings in Walgreens Boots Alliance were worth $20,073,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Cornerstone Advisors Inc. lifted its holdings in Walgreens Boots Alliance by 102.4% during the 3rd quarter. Cornerstone Advisors Inc. now owns 423 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 214 shares in the last quarter. Alpha Omega Wealth Management LLC raised its holdings in shares of Walgreens Boots Alliance by 44.8% in the 4th quarter. Alpha Omega Wealth Management LLC now owns 869 shares of the pharmacy operator’s stock valued at $59,000 after acquiring an additional 269 shares in the last quarter. Central Bank & Trust Co. purchased a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at about $98,000. Asset Dedication LLC raised its holdings in shares of Walgreens Boots Alliance by 204.6% in the 3rd quarter. Asset Dedication LLC now owns 1,578 shares of the pharmacy operator’s stock valued at $115,000 after acquiring an additional 1,060 shares in the last quarter. Finally, Ipswich Investment Management Co. Inc. bought a new position in shares of Walgreens Boots Alliance during the 4th quarter valued at about $121,000. Institutional investors own 63.07% of the company’s stock.

Several equities analysts have recently commented on the company. Zacks Investment Research lowered Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Monday, December 3rd. Morgan Stanley raised their price target on Walgreens Boots Alliance from $55.00 to $77.00 and gave the stock an “equal weight” rating in a research report on Monday, December 3rd. Goldman Sachs Group lowered Walgreens Boots Alliance from a “neutral” rating to a “sell” rating in a research report on Friday, December 14th. BidaskClub lowered Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, December 18th. Finally, Wolfe Research reiterated a “peer perform” rating on shares of Walgreens Boots Alliance in a research report on Wednesday, December 19th. Four research analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have given a buy rating to the company’s stock. Walgreens Boots Alliance currently has an average rating of “Hold” and an average target price of $78.83.

Shares of WBA stock opened at $70.12 on Friday. Walgreens Boots Alliance Inc has a 1 year low of $59.07 and a 1 year high of $86.31. The company has a current ratio of 0.80, a quick ratio of 0.36 and a debt-to-equity ratio of 0.44. The company has a market cap of $67.17 billion, a price-to-earnings ratio of 11.65, a P/E/G ratio of 1.12 and a beta of 0.98.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, December 20th. The pharmacy operator reported $1.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.43 by $0.03. The business had revenue of $33.79 billion for the quarter, compared to the consensus estimate of $33.90 billion. Walgreens Boots Alliance had a return on equity of 22.17% and a net margin of 3.96%. The company’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.28 earnings per share. On average, equities research analysts anticipate that Walgreens Boots Alliance Inc will post 6.52 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 12th. Investors of record on Friday, February 15th will be paid a $0.44 dividend. The ex-dividend date of this dividend is Thursday, February 14th. This represents a $1.76 annualized dividend and a yield of 2.51%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 29.24%.

In related news, Director Nancy M. Schlichting sold 7,050 shares of the stock in a transaction that occurred on Tuesday, November 20th. The stock was sold at an average price of $78.81, for a total value of $555,610.50. Following the transaction, the director now owns 5,709 shares of the company’s stock, valued at $449,926.29. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 15.73% of the stock is owned by corporate insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Read More: Why Dividend Stocks May Be Right for You

Related posts

Leave a Comment